Development and validation of an HPLC method for the determination of verapamil residues in supports of cleaning procedure

Journal of Analytical Chemistry

Volumn 68, Issue 6, 2013, Pages 545-551

  Milenović, Dragan M ^a   Milošević, Snežana P ^a   Durić, Svetlana Lj ^a   Nasković, Daniela Č ^a   Mitić, Snežana S ^b  

^a Zdravlje Actavis Company RandD   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

Author keywords

cleaning validation; residues; swab analysis; verapamil

Indexed keywords

ANALYTICAL METHOD VALIDATION; CLEANING VALIDATION; POTENTIAL CONTAMINANTS; RELATIVE STANDARD DEVIATIONS; RESIDUES; STAINLESS STEEL SURFACE; SWAB ANALYSIS; VERAPAMIL;

IMPURITIES; WATER INJECTION;

CLEANING;

EID: 84878730518     PISSN: 10619348     EISSN: None     Source Type: Journal    
DOI: 10.1134/S1061934813060051     Document Type: Article

References (20)

1. Guide to Inspections Validation of Cleaning Processes, U.S. Food and Drug Administration, available at: http://www.fda.gov/ICECI/Inspections/ InspectionGuides/ucm074922.htm (05/01/2011).
2. Cleaning Validation Guidance, Guidance on aspects of cleaning validation in active pharmaceutical ingredient plants, Dec. 2000, available at: http://apic.cefic.org/pub/pub-cleaning-validation.pdf (05/01/2011).
3. Guide to Cleaning Validation in API plants, Cleaning Validation in Active pharmaceutical ingredient manufacturing plants, Sep. 1999, available at: http://apic.cefic.org/pub/4CleaningVal9909.pdf (05/01/2011).
4. World Healthy Organization, Supplementary guidelines on good manufacturing practices (GMP): Validation, Working document QAS/03.055/Rev.2, pp. 24-33, available at: http://www.who.int/medicines/services/expertcommittees/ pharmprep/Validation-QAS-055-Rev2combined.pdf (05/01/2011).
5. Ozkan, Y., Yilmaz, N., Ozkan, A.S., and Biryol, I., Il Farmaco, 2000, vol. 55, no. 5, p. 376.
6. Garcia, A.M., Solans, C., Aramayona, J.J., Fraile, J.L., Bregante, A.M., and Castillo, R.J., Talanta, 1998, vol. 47, no. 5, p. 1245.
7. Venkatesh, G., Ramanathan, S., Mansor, M.S., Nair, K.N., Sattar, A.M., Croft, L.S., and Navaratnam, V., J. Pharm. Biomed. Anal., 2007, vol. 43, no. 4, p. 1546.
8. Valvo, L., Alimenti, R., Alimonti, S., Raimondi, S., Foglietta, F., and Campana, F., J. Pharm. Biomed. Anal., 1997, vol. 15, no. 7, p. 989.
9. Lacroix, M.P., Graham, J.S., and Lovering, G.E., J. Pharm. Biomed. Anal., 1991, vol. 9, no. 10-12, p. 817.
10. He, L. and Wang, S., Arch. Pharm. Res., 2003, vol. 26, no. 9, p. 763.
11. Chen, L.G., Li, F.Y., and Lee, Y.F., Chin. Pharmaceut. J., 2000, vol. 52, no. 2, p. 113.
12. Gupta, D.V., Drug Develop. Ind. Pharm., 1985, vol. 11, no. 8, p. 1497.
13. Nahata, C.M., J. Appl. Therap., 1997, vol. 1, no. 3, p. 271.
14. Gumieniczek, A. and Hopkala, H., J. Liq. Chrom. R. T., 2001, vol. 24, no. 3, p. 393.
15. Kasturi, K., Rao, S.D., Sundaram, R., and Pharma, T., Ind. Drugs, 1984, vol. 21, no. 10, p. 463.
16. Tsilifonis, C.D., Wilk, K., Reisch, R., and Daly, E.R., J. Liq. Chrom., 1985, vol. 8, no. 3, p. 499.
17. Yazan, Y. and Bozan, B., Pharmazie, 1995, vol. 50, no. 2, p. 117.
18. ElGhany, M.F.A., Moustafa, A.A., Elzeany, E.B., and Stewart, T.J., J. Plan. Chromatogr. Mod. TLC, 1996, vol. 9, no. 5, p. 388.
19. Eiden, F. and Karin, G.B., Pharm. Zeit., 1984, vol. 129, no. 12, p. 678.
20. International Conference on Harmonization Q2 (R1): Validation of Analytical Procedures: Text and Methodology, available at: http://www.ich.org/ fileadmin/Public-Web-Site/ICH-Products/Guidelines/Quality/Q2-R1/Step4/ Q2-R1-Guideline.pdf (05/01/2011).